[Implementation and use of biosimilars in the therapy of inflammatory rheumatic diseases: Statement of the German Society of Rheumatology].
Sektion Rheumatologie, Abteilung Innere Medizin V, Universitätsklinikum Heidelberg, ACURA-Rheumazentrum Baden-Baden, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland, hannes.lorenz@med.uni-heidelberg.de.
H-M
HM
Lorenz
J
J
Braun
K
K
Krüger
M
M
Schneider
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000592:standards* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D059451:Biosimilar Pharmaceuticals / Q000592:standards* / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000592:standards*; D012955:Societies, Medical / Q000592:standards
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D059451:Biosimilar Pharmaceuticals